Focus: Fable Therapeutics is an AI-driven protein design company focused on infectious disease therapeutics, headquartered in Boston. The company is at an early stage with a nascent pipeline and minimal disclosed financial metrics.
Profile data last refreshed 13h ago · AI intelligence enriched 2w ago
Stable — net -2 jobs in 30d
0 added, 2 removed. Backfill posture.
Fable is a speculative early-stage platform play best suited for scientists and technologists seeking foundational impact and equity upside, not stability or near-term revenue visibility.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Fable Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Fable Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles